Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for disorders of consciousness
2018-003144-23Phase 2Active
- Sponsor
- University of Liège
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of apomorphine in disorder of consciousness (DOC), sponsored by University of Liège. Primary endpoint: Change in CRS-R diagnosis and scores. Started Aug 2018; status: active.
02
Drugs
apomorphine
03
Conditions
disorder of consciousness (DOC)
Beyond the preview
Go deeper on 2018-003144-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003144-23.